LIFE Expands in Diagnostics Market – Analyst BlogNASDAQLast month, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. According to the company, the Applied Biosystems 3500 Dx/3500xL Dx CS2 Genetic Analyz…
LIFE Expands in Diagnostics MarketZacks.comLast month, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. According to the company, the Applied Biosystems 3500 Dx/3500xL Dx CS2 Genetic Analyzers, Invitro…
|
Paired Ends: Paul Grint, Gary Wu, Martin Blaser, Jeffrey Gordon, Gail Hecht …
GenomeWeb … for marketing in the US. The 510(k) clearance further extends Life Tech’s presence in the diagnostics space, following its launch of the Pervenio Lung RS test, and last month’s FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. |
|
Quidel And Life Technologies Receive FDA Clearance For Clostridium Difficile …
Daily Markets (press release) In February 2013, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The Quidel Molecular Direct C. difficile Assay is Quidel’s first assay with a streamlined stool processing procedure. Quidel also … |
|
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile …
Marketwire (press release) In February 2013, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The Quidel Molecular Direct C. difficile Assay is Quidel’s first assay with a streamlined stool processing procedure. Quidel also … |
|
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile …
MarketWatch (press release) In February 2013, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore(R) HLA typing kits. The Quidel Molecular Direct C. difficile Assay is Quidel’s first assay with a streamlined stool processing procedure. Quidel also … |
|
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile …
PR Newswire (press release) In February 2013, the company received 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The Quidel Molecular Direct C. difficile Assay is Quidel’s first assay with a streamlined stool processing procedure. Quidel also … |
|
IP Update: Microsoft, IBM, and Affymetrix among Recent Bioinformatics Patent …
GenomeWeb … for marketing in the US. The 510(k) clearance further extends Life Tech’s presence in the diagnostics space, following its launch of the Pervenio Lung RS test, and last month’s FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. |
|
Jury Orders Illumina to Pay $96M for Infringing Syntrix’s Array IP
GenomeWeb … for marketing in the US. The 510(k) clearance further extends Life Tech’s presence in the diagnostics space, following its launch of the Pervenio Lung RS test, and last month’s FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. |
|
American College of Cardiology 2013 Abstracts Explore PGx, Prognostic …
GenomeWeb … for marketing in the US. The 510(k) clearance further extends Life Tech’s presence in the diagnostics space, following its launch of the Pervenio Lung RS test, and last month’s FDA clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. |